Register Login
Register to leave comments
  • News bot May 7, 2026, 10:07 a.m.

    📋 GENERATE BIOMEDICINES, INC. (GENB) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 06:00:26

    Event Type: Financial Results

    Event Details:

    GENERATE BIOMEDICINES, INC. (GENB) Reports the reporting period Financial Results GENERATE BIOMEDICINES, INC. (GENB) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 7224
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 339
      • expected in mid-2026
      • expected in the second half of 2026
      • targeting ovarian cancer. Financial Results Cash, cash equivalents, and marketable securities were $516.6 million as of March 31, 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 18.75K 12.53K $6.22K +49.66%
    Current Assets Property Equipment Net 27.84K 29.15K $-1.31K -4.51%
    Current Assets Operating Lease Right Of Use Assets 57.77K 59.86K $-2.10K -3.50%
    Current Assets Other Assets 4.75K 6.81K $-2.06K -30.28%
    Current Liabilities Accounts Payable 7.62K 3.84K $3.78K +98.51%
    Operating Expenses Loss From Operations 64.11K 48.15K $15.96K +33.14%
    Other Income Expense Net Interest Expense 182.00 368.00 $-186.00 -50.54%
    Other Income Expense Net Interest Income 2.91K 4.28K $-1.37K -31.96%
    Other Expense Total Other Income Expense 2.43K 3.90K $-1.47K -37.73%
    Other Expense Net Loss 61.71K 44.31K $17.40K +39.27%
    Prepaid Expenses and Other Current Assets 18.75K 12.53K $6.22K +49.66%
    Property and Equipment, Net 27.84K 29.15K $-1.31K -4.51%
    Other Assets 4.75K 6.81K $-2.06K -30.28%
    Accounts Payable 7.62K 3.84K $3.78K +98.51%
    Revenue 17.24K 21.19K $-3.95K -18.64%
    Operating Lease Liabilities 10.38K 10.70K $-319.00 -2.98%
    Loss from Operations 64.11K 48.15K $15.96K +33.14%
    Interest Expense 182.00 368.00 $-186.00 -50.54%
    Interest Income 2.91K 4.28K $-1.37K -31.96%
    Total Other Income/(Expense) 2.43K 3.90K $-1.47K -37.73%
    Net Loss 61.71K 44.31K $17.40K +39.27%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: GENERATE BIOMEDICINES, INC.
    • Ticker Symbol: GENB

Search

News categories